101 related articles for article (PubMed ID: 4430323)
21. Measurement of 3-methoxy-4-hydroxyphenylglycol sulfate ester in brain using reversed-phase liquid chromatography and electrochemical detection.
Hornsperger JM; Wagner J; Hinkel JP; Jung MJ
J Chromatogr; 1984 Mar; 306():364-70. PubMed ID: 6715474
[No Abstract] [Full Text] [Related]
22. The effects of acute and chronic morphine administration on the levels of 3-methoxy-4-hydroxphenylglycol sulfate in rat brain.
Roffman M; Reigle T; Orsulak P; Schildkraut JJ
Res Commun Chem Pathol Pharmacol; 1975 Mar; 10(3):403-17. PubMed ID: 1135507
[TBL] [Abstract][Full Text] [Related]
23. Action of S 1432, a new psychotropic drug, on the central cholinergic system.
Consolo S; Ladinsky H; Peri G; Garattini S
Biochem Pharmacol; 1977 Aug; 26(16):1517-20. PubMed ID: 901570
[No Abstract] [Full Text] [Related]
24. The influence of piribedil (ET495) on components of locomotor activity.
Jenner P; Marsden CD
Eur J Pharmacol; 1975 Aug; 33(1):211-5. PubMed ID: 1175688
[TBL] [Abstract][Full Text] [Related]
25. Effects of imipramine on behavior and brain norepinephrine metabolism in tetrabenazine treated rats: comparative study of a single administration with repeated administrations of imipramine.
Hori A; Nakagawara M; Kariya T; Watanabe A
Folia Psychiatr Neurol Jpn; 1983; 37(4):465-74. PubMed ID: 6543815
[TBL] [Abstract][Full Text] [Related]
26. Plasma and cerebrospinal fluid 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) as indices of brain norepinephrine metabolism in primates.
Elsworth JD; Redmond DE; Roth RH
Brain Res; 1982 Mar; 235(1):115-24. PubMed ID: 7188317
[TBL] [Abstract][Full Text] [Related]
27. A method for the assay of conjugated 3,4-dihydroxyphenylglycol, a major noradrenaline metabolite in the rat brain.
Nielsen M; Braestrup C
J Neurochem; 1976 Nov; 27(5):1211-7. PubMed ID: 12170609
[TBL] [Abstract][Full Text] [Related]
28. Brain-noradrenaline and 3-methoxy-4-hydroxyphenylglycol in Parkinson's syndrome.
Riederer P; Birkmayer W; Seemann D; Wuketich S
J Neural Transm; 1977; 41(4):241-51. PubMed ID: 925685
[TBL] [Abstract][Full Text] [Related]
29. The influence of mianserin and danitracen on the disappearance of noradrenaline in the rat brain.
Klimek V; Mogilnicka E
Pol J Pharmacol Pharm; 1978; 30(2-3):255-61. PubMed ID: 673929
[No Abstract] [Full Text] [Related]
30. [Effect of progesterone on noradrenaline metabolism in the brain of ovariectomized rats].
Ladisich W; Baumann P
Arzneimittelforschung; 1970 Jul; 20(7):906-8. PubMed ID: 5536055
[No Abstract] [Full Text] [Related]
31. Increase of 3-methoxy-4-hydroxyphenylethylene glycol in rat brain by neuroleptic drugs.
Keller HH; Bartholini G; Pletscher A
Eur J Pharmacol; 1973 Aug; 23(2):183-6. PubMed ID: 4733777
[No Abstract] [Full Text] [Related]
32. A time-dependent biphasic effect of an acute ethanol injection on 3-methoxy 4-hydroxyphenylethylene glycol sulfate in rat brain.
Smith BR; Aragon CM; Amit Z
Biochem Pharmacol; 1985 Apr; 34(8):1311-4. PubMed ID: 3994748
[TBL] [Abstract][Full Text] [Related]
33. Determination of the primary metabolite of central nervous system norepinephrine, 3-methoxy-4-hydroxy-phenethyleneglycol, in mouse brain and brain perfusate by high-performance liquid chromatography with electrochemical detection.
Towell JF; Erwin VG
J Chromatogr; 1981 May; 223(2):295-303. PubMed ID: 7251783
[TBL] [Abstract][Full Text] [Related]
34. Assay of brain 3,4-dihydroxyphenylethyleneglycol (DHPG) levels by high-performance liquid chromatography with electrochemical detection. Factors affecting stability during sample preparation.
Howes LG; Summers RJ; Rowe PR; Louis WJ
J Chromatogr; 1984 Mar; 287(1):133-5. PubMed ID: 6725453
[No Abstract] [Full Text] [Related]
35. Effects of cyanamide on body weight and brain monoamines and metabolites in rats.
Obach R; Menargues A; Vallès J; Vallès JM; García-Sevilla JA
Eur J Pharmacol; 1986 Aug; 127(3):225-31. PubMed ID: 3758181
[TBL] [Abstract][Full Text] [Related]
36. Niaprazine, a selective brain catecholamine depletor.
Keane PE; Benedetti MS
Neuropharmacology; 1979 Jul; 18(7):595-600. PubMed ID: 158713
[No Abstract] [Full Text] [Related]
37. Effect of pergolide on MOPEG sulphate levels in rat brain regions.
Fuller RW; Perry KW
J Pharm Pharmacol; 1983 Jan; 35(1):57-8. PubMed ID: 6131970
[No Abstract] [Full Text] [Related]
38. The effect of tranquillizing drugs on the concentration of the sulphate ester of 4-hydroxy-3-methoxyphenylethane-1,2-diol in rat brain.
Berridge TL; Sharman DF
Br J Pharmacol; 1974 Jan; 50(1):156-8. PubMed ID: 4823464
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of action of piribedil on noradrenergic neurons in rat brain.
Bareggi SR; Markey K; Paoletti R
Biochem Pharmacol; 1978; 27(24):2803-5. PubMed ID: 736975
[No Abstract] [Full Text] [Related]
40. Lack of effects of chlordecone on synthesis rates, steady state levels and metabolites of catecholamines in rat brain.
Aldous CN; Chetty CS; Mehendale HM; Desaiah D
Neurotoxicology; 1984; 5(2):59-65. PubMed ID: 6209598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
